RIVAROXABAN HAS DEMONSTRATED AN ADVANTAGE OVER ACETYLSALICYLIC ACID IN PREVENTING THE RECURRENCE OF VENOUS THROMBOEMBOLIC EVENTS IN THE EINSTEIN CHOICE STUDY

Press Release of Bayer AG

Saved in:

Bibliographic Details
Main Author:	. Editorial (Author)
Format:	Book
Published:	Столичная издательская компания, 2017-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet

Holdings details from 3rd Floor Main Library
Call Number:	A1234.567
Copy 1	Available